Many of the phenotypic changes observed during tumor progression in SPARC−/− mice, such as enhanced vascular permeability, increased metastasis, decreased survival and altered immune tolerance, are consistent with elevated TGFβ activity [16], [17], [32], [33]. The gene discussed is TGFB1; the disease is neoplasm.